188 related articles for article (PubMed ID: 27336043)
21. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia.
Gao XM; Sakai K; Roberts RC; Conley RR; Dean B; Tamminga CA
Am J Psychiatry; 2000 Jul; 157(7):1141-9. PubMed ID: 10873924
[TBL] [Abstract][Full Text] [Related]
22. Organization of postsynaptic density proteins and glutamate receptors in axodendritic and dendrodendritic synapses of the rat olfactory bulb.
Sassoé-Pognetto M; Utvik JK; Camoletto P; Watanabe M; Stephenson FA; Bredt DS; Ottersen OP
J Comp Neurol; 2003 Aug; 463(3):237-48. PubMed ID: 12820158
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation.
Turnock-Jones JJ; Jennings CA; Robbins MJ; Cluderay JE; Cilia J; Reid JL; Taylor A; Jones DN; Emson PC; Southam E
Synapse; 2009 Oct; 63(10):836-46. PubMed ID: 19533626
[TBL] [Abstract][Full Text] [Related]
24. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics.
Akbarian S; Sucher NJ; Bradley D; Tafazzoli A; Trinh D; Hetrick WP; Potkin SG; Sandman CA; Bunney WE; Jones EG
J Neurosci; 1996 Jan; 16(1):19-30. PubMed ID: 8613785
[TBL] [Abstract][Full Text] [Related]
25. The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.
Ju P; Cui D
Acta Biochim Biophys Sin (Shanghai); 2016 Mar; 48(3):209-19. PubMed ID: 26837414
[TBL] [Abstract][Full Text] [Related]
26. A quantitative review of the postmortem evidence for decreased cortical N-methyl-D-aspartate receptor expression levels in schizophrenia: How can we link molecular abnormalities to mismatch negativity deficits?
Catts VS; Lai YL; Weickert CS; Weickert TW; Catts SV
Biol Psychol; 2016 Apr; 116():57-67. PubMed ID: 26549579
[TBL] [Abstract][Full Text] [Related]
27. Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs.
Fumagalli F; Frasca A; Racagni G; Riva MA
Mol Pharmacol; 2008 May; 73(5):1484-90. PubMed ID: 18250147
[TBL] [Abstract][Full Text] [Related]
28. NMDA NR1 subunit mRNA and glutamate NMDA-sensitive binding are differentially affected in the striatum and pre-frontal cortex of Parkinson's disease patients.
Meoni P; Bunnemann BH; Kingsbury AE; Trist DG; Bowery NG
Neuropharmacology; 1999 May; 38(5):625-33. PubMed ID: 10340300
[TBL] [Abstract][Full Text] [Related]
29. Further characterization of the molecular interaction between PSD-95 and NMDA receptors: the effect of the NR1 splice variant and evidence for modulation of channel gating.
Rutter AR; Freeman FM; Stephenson FA
J Neurochem; 2002 Jun; 81(6):1298-307. PubMed ID: 12068077
[TBL] [Abstract][Full Text] [Related]
30. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
31. Alterations in long-term seizure susceptibility and the complex of PSD-95 with NMDA receptor from animals previously exposed to perinatal hypoxia.
Chen WF; Chang H; Huang LT; Lai MC; Yang CH; Wan TH; Yang SN
Epilepsia; 2006 Feb; 47(2):288-96. PubMed ID: 16499752
[TBL] [Abstract][Full Text] [Related]
32. Regional-specific effects of cerebral ischemia/reperfusion and dehydroepiandrosterone on synaptic NMDAR/PSD-95 complex in male Wistar rats.
Zaric M; Drakulic D; Stojanovic IG; Mitrovic N; Grkovic I; Martinovic J
Brain Res; 2018 Jun; 1688():73-80. PubMed ID: 29577884
[TBL] [Abstract][Full Text] [Related]
33. D-Serine and Serine Racemase Are Associated with PSD-95 and Glutamatergic Synapse Stability.
Lin H; Jacobi AA; Anderson SA; Lynch DR
Front Cell Neurosci; 2016; 10():34. PubMed ID: 26941605
[TBL] [Abstract][Full Text] [Related]
34. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.
Duncan GE; Moy SS; Perez A; Eddy DM; Zinzow WM; Lieberman JA; Snouwaert JN; Koller BH
Behav Brain Res; 2004 Aug; 153(2):507-19. PubMed ID: 15265649
[TBL] [Abstract][Full Text] [Related]
35. Glutamate signaling proteins and tyrosine hydroxylase in the locus coeruleus of alcoholics.
Karolewicz B; Johnson L; Szebeni K; Stockmeier CA; Ordway GA
J Psychiatr Res; 2008 Apr; 42(5):348-55. PubMed ID: 17481661
[TBL] [Abstract][Full Text] [Related]
36. Cocaine treatment- and withdrawal-induced alterations in the expression and serine phosphorylation of the NR1 NMDA receptor subunit.
Loftis JM; Janowsky A
Psychopharmacology (Berl); 2002 Dec; 164(4):349-59. PubMed ID: 12457264
[TBL] [Abstract][Full Text] [Related]
37. Chronic corticosterone exposure alters postsynaptic protein levels of PSD-95, NR1, and synaptopodin in the mouse brain.
Cohen JW; Louneva N; Han LY; Hodes GE; Wilson RS; Bennett DA; Lucki I; Arnold SE
Synapse; 2011 Aug; 65(8):763-70. PubMed ID: 21190219
[TBL] [Abstract][Full Text] [Related]
38. Lurasidone and fluoxetine reduce novelty-induced hypophagia and NMDA receptor subunit and PSD-95 expression in mouse brain.
Stan TL; Sousa VC; Zhang X; Ono M; Svenningsson P
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1714-22. PubMed ID: 26256011
[TBL] [Abstract][Full Text] [Related]
39. Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.
McCullumsmith RE; Kristiansen LV; Beneyto M; Scarr E; Dean B; Meador-Woodruff JH
Brain Res; 2007 Jan; 1127(1):108-18. PubMed ID: 17113057
[TBL] [Abstract][Full Text] [Related]
40. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function.
Duncan G; Miyamoto S; Gu H; Lieberman J; Koller B; Snouwaert J
Brain Res; 2002 Oct; 951(2):166-76. PubMed ID: 12270494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
